{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T17:52:03Z","timestamp":1791395523375,"version":"4.3.3"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Med"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s00109-026-02727-0","type":"journal-article","created":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T04:26:03Z","timestamp":1791347163000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Human epididymis protein 4 is a predictor of long-term mortality and major adverse cardiovascular events in patients with coronary artery disease"],"prefix":"10.1007","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5582-4125","authenticated-orcid":false,"given":"Axel","family":"Muendlein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Heinzle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrin","family":"Geiger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva Maria","family":"Brandtner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Schnetzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelika","family":"Hammerer-Lercher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph H.","family":"Saely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinz","family":"Drexel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Leiherer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,7]]},"reference":[{"key":"2727_CR1","doi-asserted-by":"publisher","unstructured":"Giubilato S, Luc\u00e0 F, Abrignani MG et al (2023) Management of residual risk in chronic coronary syndromes. Clinical pathways for a quality-based secondary prevention. J Clin Med 12. https:\/\/doi.org\/10.3390\/JCM12185989","DOI":"10.3390\/JCM12185989"},{"key":"2727_CR2","doi-asserted-by":"publisher","first-page":"2458","DOI":"10.1161\/CIR.0B013E318235EB4D","volume":"124","author":"SC Smith","year":"2011","unstructured":"Smith SC, Benjamin EJ, Bonow RO et al (2011) AHA\/ACCF Secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation. Circulation 124:2458\u20132473. https:\/\/doi.org\/10.1161\/CIR.0B013E318235EB4D","journal-title":"Circulation"},{"key":"2727_CR3","doi-asserted-by":"publisher","unstructured":"Zeitouni M, Clare RM, Chiswell K et al (2020) Risk factor burden and long-term prognosis of patients with premature coronary artery disease. J Am Heart Assoc 9. https:\/\/doi.org\/10.1161\/JAHA.120.017712","DOI":"10.1161\/JAHA.120.017712"},{"key":"2727_CR4","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1136\/HEARTJNL-2013-303640","volume":"99","author":"JAN Dorresteijn","year":"2013","unstructured":"Dorresteijn JAN, Visseren FLJ, Wassink AMJ et al (2013) Development and validation of a prediction rule for recurrent vascular events based on a cohort study of patients with arterial disease: the SMART risk score. Heart 99:866\u2013872. https:\/\/doi.org\/10.1136\/HEARTJNL-2013-303640","journal-title":"Heart"},{"key":"2727_CR5","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/J.JACC.2017.06.030","volume":"70","author":"D Lindholm","year":"2017","unstructured":"Lindholm D, Lindb\u00e4ck J, Armstrong PW et al (2017) Biomarker-based risk model to predict cardiovascular mortality in patients with stable coronary disease. J Am Coll Cardiol 70:813\u2013826. https:\/\/doi.org\/10.1016\/J.JACC.2017.06.030","journal-title":"J Am Coll Cardiol"},{"key":"2727_CR6","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1001\/JAMA.297.2.169","volume":"297","author":"K Bibbins-Domingo","year":"2007","unstructured":"Bibbins-Domingo K, Gupta R, Na B et al (2007) N-terminal fragment of the prohormone brain-type natriuretic peptide (NT-proBNP), cardiovascular events, and mortality in patients with stable coronary heart disease. JAMA 297:169\u2013176. https:\/\/doi.org\/10.1001\/JAMA.297.2.169","journal-title":"JAMA"},{"key":"2727_CR7","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/J.JACC.2007.03.038","volume":"50","author":"T Omland","year":"2007","unstructured":"Omland T, Sabatine MS, Jablonski KA et al (2007) Prognostic value of B-Type natriuretic peptides in patients with stable coronary artery disease: the PEACE Trial. J Am Coll Cardiol 50:205\u2013214. https:\/\/doi.org\/10.1016\/J.JACC.2007.03.038","journal-title":"J Am Coll Cardiol"},{"key":"2727_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/S41572-019-0106-Z","author":"P Libby","year":"2019","unstructured":"Libby P, Buring JE, Badimon L et al (2019) Atherosclerosis. Nat Rev Dis Prim. https:\/\/doi.org\/10.1038\/S41572-019-0106-Z. 5:","journal-title":"Nat Rev Dis Prim"},{"key":"2727_CR9","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1093\/cvr\/cvaa324","volume":"117","author":"NG Frangogiannis","year":"2021","unstructured":"Frangogiannis NG (2021) Cardiac fibrosis. Cardiovasc Res 117:1450\u20131488. https:\/\/doi.org\/10.1093\/cvr\/cvaa324","journal-title":"Cardiovasc Res"},{"key":"2727_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/J.JACC.2025.08.047","author":"GA Mensah","year":"2025","unstructured":"Mensah GA, Arnold N, Prabhu SD et al (2025) Inflammation and cardiovascular disease: 2025 ACC scientific statement: a report of the american college of cardiology. J Am Coll Cardiol. https:\/\/doi.org\/10.1016\/J.JACC.2025.08.047","journal-title":"J Am Coll Cardiol"},{"key":"2727_CR11","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1007\/S00109-015-1314-Y","volume":"93","author":"T Moore-Morris","year":"2015","unstructured":"Moore-Morris T, Guimar\u00e3es-Camboa N, Yutzey KE et al (2015) Cardiac fibroblasts: from development to heart failure. J Mol Med (Berl) 93:823\u2013830. https:\/\/doi.org\/10.1007\/S00109-015-1314-Y","journal-title":"J Mol Med (Berl)"},{"key":"2727_CR12","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/J.ATHEROSCLEROSIS.2018.07.014","volume":"276","author":"P Raggi","year":"2018","unstructured":"Raggi P, Genest J, Giles JT et al (2018) Role of inflammation in the pathogenesis of atherosclerosis and therapeutic interventions. Atherosclerosis 276:98\u2013108. https:\/\/doi.org\/10.1016\/J.ATHEROSCLEROSIS.2018.07.014","journal-title":"Atherosclerosis"},{"key":"2727_CR13","doi-asserted-by":"publisher","unstructured":"de Villiers CB, Plans-Beriso E, Erady C et al (2025) Biomarkers for personalised primary or secondary prevention in cardiovascular diseases: a rapid scoping review. Int J Mol Sci 26. https:\/\/doi.org\/10.3390\/IJMS26199346","DOI":"10.3390\/IJMS26199346"},{"key":"2727_CR14","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/J.ATHEROSCLEROSIS.2015.05.007","volume":"241","author":"C Vlachopoulos","year":"2015","unstructured":"Vlachopoulos C, Xaplanteris P, Aboyans V et al (2015) The role of vascular biomarkers for primary and secondary prevention. A position paper from the European Society of Cardiology Working Group on peripheral circulation: Endorsed by the Association for Research into Arterial Structure and Physiology (ARTERY) Society. Atherosclerosis 241:507\u2013532. https:\/\/doi.org\/10.1016\/J.ATHEROSCLEROSIS.2015.05.007","journal-title":"Atherosclerosis"},{"key":"2727_CR15","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1158\/0008-5472.CAN-04-3924","volume":"65","author":"R Drapkin","year":"2005","unstructured":"Drapkin R, Von Horsten HH, Lin Y et al (2005) Human epididymis protein 4 (HE4) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas. Cancer Res 65:2162\u20132169. https:\/\/doi.org\/10.1158\/0008-5472.CAN-04-3924","journal-title":"Cancer Res"},{"key":"2727_CR16","doi-asserted-by":"publisher","unstructured":"Liu Y, Liu B, Gao H et al (2025) HE4 might participate in extracellular matrix remodeling in ovarian cancer via activation of fibroblasts. Oncol Res 34. https:\/\/doi.org\/10.32604\/OR.2025.069007","DOI":"10.32604\/OR.2025.069007"},{"key":"2727_CR17","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/J.CHEST.2016.04.006","volume":"150","author":"B Nagy","year":"2016","unstructured":"Nagy B, Nagy B, Fila L et al (2016) Human epididymis protein 4: a novel serum inflammatory biomarker in cystic fibrosis. Chest 150:661\u2013672. https:\/\/doi.org\/10.1016\/J.CHEST.2016.04.006","journal-title":"Chest"},{"key":"2727_CR18","doi-asserted-by":"publisher","unstructured":"Yamamoto M, Hanatani S, Araki S et al (2021) HE4 predicts progressive fibrosis and cardiovascular events in patients with dilated cardiomyopathy. J Am Heart Assoc 10. https:\/\/doi.org\/10.1161\/JAHA.120.021069","DOI":"10.1161\/JAHA.120.021069"},{"key":"2727_CR19","doi-asserted-by":"publisher","unstructured":"Giuliani C, Zanuttini A, Nuche J et al (2025) Human epididymis protein 4 in transcatheter aortic valve implantation: diagnostic and prognostic value. JACC Adv 4. https:\/\/doi.org\/10.1016\/J.JACADV.2025.101722","DOI":"10.1016\/J.JACADV.2025.101722"},{"key":"2727_CR20","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/NM.2989","volume":"19","author":"VS LeBleu","year":"2013","unstructured":"LeBleu VS, Teng Y, O\u2019Connell JT et al (2013) Identification of human epididymis protein-4 as a fibroblast-derived mediator of fibrosis. Nat Med 19:227\u2013231. https:\/\/doi.org\/10.1038\/NM.2989","journal-title":"Nat Med"},{"key":"2727_CR21","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1161\/CIRCULATIONAHA.124.070454","volume":"151","author":"FK Ho","year":"2025","unstructured":"Ho FK, Mark PB, Lees JS et al (2025) A proteomics-based approach for prediction of different cardiovascular diseases and dementia. Circulation 151:277\u2013287. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.124.070454","journal-title":"Circulation"},{"key":"2727_CR22","doi-asserted-by":"publisher","DOI":"10.1093\/PROCEL\/PWAF072","author":"Y-L Chen","year":"2025","unstructured":"Chen Y-L, Wang J-J, You J et al (2025) Systematic analyses uncover plasma proteins linked to incident cardiovascular diseases. Protein Cell. https:\/\/doi.org\/10.1093\/PROCEL\/PWAF072","journal-title":"Protein Cell"},{"key":"2727_CR23","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/J.JCHF.2012.11.005","volume":"1","author":"RA De Boer","year":"2013","unstructured":"De Boer RA, Cao Q, Postmus D et al (2013) The WAP four-disulfide core domain protein HE4: a novel biomarker for heart failure. JACC Heart Fail 1:164\u2013169. https:\/\/doi.org\/10.1016\/J.JCHF.2012.11.005","journal-title":"JACC Heart Fail"},{"key":"2727_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/FCVM.2025.1530271","author":"Y Tang","year":"2025","unstructured":"Tang Y, Chen Y, Huang XJ et al (2025) The level of human epididymis protein 4 is associated with poor prognosis in patients with ejection fraction preserved heart failure. Front Cardiovasc Med. https:\/\/doi.org\/10.3389\/FCVM.2025.1530271. 12:","journal-title":"Front Cardiovasc Med"},{"key":"2727_CR25","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/J.CARDFAIL.2016.05.002","volume":"23","author":"A Piek","year":"2017","unstructured":"Piek A, Meijers WC, Schroten NF et al (2017) HE4 serum levels are associated with heart failure severity in patients with chronic heart failure. J Card Fail 23:12\u201319. https:\/\/doi.org\/10.1016\/J.CARDFAIL.2016.05.002","journal-title":"J Card Fail"},{"key":"2727_CR26","doi-asserted-by":"publisher","first-page":"6243","DOI":"10.2147\/IJGM.S470399","volume":"17","author":"Y Tang","year":"2024","unstructured":"Tang Y, Zhu W-Y, Peng S-L et al (2024) Prognostic value of human epididymis protein 4 in acute myocardial infarction. Int J Gen Med 17:6243\u20136251. https:\/\/doi.org\/10.2147\/IJGM.S470399","journal-title":"Int J Gen Med"},{"key":"2727_CR27","doi-asserted-by":"publisher","unstructured":"Muendlein A, Heinzle C, Geiger K et al (2026) Circulating human epididymis protein 4 predicts 10-year mortality and major adverse cardiovascular events in patients with peripheral artery disease. Eur J Clin Invest 56. https:\/\/doi.org\/10.1111\/ECI.70236","DOI":"10.1111\/ECI.70236"},{"key":"2727_CR28","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1161\/01.CIR.90.5.2230","volume":"90","author":"H Drexel","year":"1994","unstructured":"Drexel H, Amann FW, Beran J et al (1994) Plasma triglycerides and three lipoprotein cholesterol fractions are independent predictors of the extent of coronary atherosclerosis. Circulation 90:2230\u20132235","journal-title":"Circulation"},{"key":"2727_CR29","first-page":"S1","volume":"38","author":"American Diabetes Association","year":"2015","unstructured":"American Diabetes Association (2015) Standards of medical care in diabetes-2015. Diabetes Care 38:S1\u2013S93","journal-title":"Diabetes Care"},{"key":"2727_CR30","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1093\/EURHEARTJ\/EHT151","volume":"34","author":"G Mancia","year":"2013","unstructured":"Mancia G, Fagard R, Narkiewicz K et al (2013) 2013 ESH\/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 34:2159\u20132219. https:\/\/doi.org\/10.1093\/EURHEARTJ\/EHT151","journal-title":"Eur Heart J"},{"key":"2727_CR31","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH et al (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150:604\u2013612. https:\/\/doi.org\/10.7326\/0003-4819-150-9-200905050-00006","journal-title":"Ann Intern Med"},{"key":"2727_CR32","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1111\/JOIM.13368","volume":"290","author":"A Leiherer","year":"2021","unstructured":"Leiherer A, M\u00fcndlein A, Brandtner EM et al (2021) Lipid profiles of patients with manifest coronary versus peripheral atherosclerosis - Is there a difference? J Intern Med 290:1249\u20131263. https:\/\/doi.org\/10.1111\/JOIM.13368","journal-title":"J Intern Med"},{"key":"2727_CR33","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/J.ATHEROSCLEROSIS.2015.01.021","volume":"239","author":"P Rein","year":"2015","unstructured":"Rein P, Saely CH, Silbernagel G et al (2015) Systemic inflammation is higher in peripheral artery disease than in stable coronary artery disease. Atherosclerosis 239:299\u2013303. https:\/\/doi.org\/10.1016\/J.ATHEROSCLEROSIS.2015.01.021","journal-title":"Atherosclerosis"},{"key":"2727_CR34","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1161\/01.CIR.0000137913.26087.F0","volume":"110","author":"E Selvin","year":"2004","unstructured":"Selvin E, Erlinger TP (2004) Prevalence of and risk factors for peripheral arterial disease in the United States: Results from the National Health and Nutrition Examination Survey, 1999\u20132000. Circulation 110:738\u2013743. https:\/\/doi.org\/10.1161\/01.CIR.0000137913.26087.F0","journal-title":"Circulation"},{"key":"2727_CR35","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1530\/ror.0.0030086","volume":"3","author":"C Kirchhoff","year":"1998","unstructured":"Kirchhoff C (1998) Molecular characterization of epididymal proteins. Rev Reprod 3:86\u201395. https:\/\/doi.org\/10.1530\/ror.0.0030086","journal-title":"Rev Reprod"},{"key":"2727_CR36","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1095\/biolreprod45.2.350","volume":"45","author":"C Kirchhoff","year":"1991","unstructured":"Kirchhoff C, Habben I, Iveli R, Krull N (1991) A major human epididymis-specific cDNA encodes a protein with sequence homology to extracellular proteinase inhibitors. Biol Reprod 45:350\u2013357. https:\/\/doi.org\/10.1095\/biolreprod45.2.350","journal-title":"Biol Reprod"},{"key":"2727_CR37","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1038\/MODPATHOL.3800612","volume":"19","author":"MT Galgano","year":"2006","unstructured":"Galgano MT, Hampton GM, Frierson HF (2006) Comprehensive analysis of HE4 expression in normal and malignant human tissues. Mod Pathol 19:847\u2013853. https:\/\/doi.org\/10.1038\/MODPATHOL.3800612","journal-title":"Mod Pathol"},{"key":"2727_CR38","doi-asserted-by":"publisher","unstructured":"Olejarz W, \u0141acheta D, Kubiak-Tomaszewska G (2020) Matrix metalloproteinases as biomarkers of atherosclerotic plaque instability. Int J Mol Sci 21. https:\/\/doi.org\/10.3390\/IJMS21113946","DOI":"10.3390\/IJMS21113946"},{"key":"2727_CR39","doi-asserted-by":"publisher","first-page":"2554","DOI":"10.1096\/FJ.201901950R","volume":"34","author":"L Zhang","year":"2020","unstructured":"Zhang L, Liu L, Bai M et al (2020) Hypoxia-induced HE4 in tubular epithelial cells promotes extracellular matrix accumulation and renal fibrosis via NF-\u03baB. FASEB J 34:2554\u20132567. https:\/\/doi.org\/10.1096\/FJ.201901950R","journal-title":"FASEB J"},{"key":"2727_CR40","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/J.CCA.2018.05.006","volume":"483","author":"J Luo","year":"2018","unstructured":"Luo J, Wang F, Wan J et al (2018) Serum human epididymis secretory protein 4 as a potential biomarker of renal fibrosis in kidney transplantation recipients. Clin Chim Acta 483:216\u2013221. https:\/\/doi.org\/10.1016\/J.CCA.2018.05.006","journal-title":"Clin Chim Acta"},{"key":"2727_CR41","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/J.IT.2008.07.001","volume":"29","author":"CD Bingle","year":"2008","unstructured":"Bingle CD, Vyakarnam A (2008) Novel innate immune functions of the whey acidic protein family. Trends Immunol 29:444\u2013453. https:\/\/doi.org\/10.1016\/J.IT.2008.07.001","journal-title":"Trends Immunol"}],"container-title":["Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-026-02727-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00109-026-02727-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-026-02727-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T17:02:18Z","timestamp":1791392538000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00109-026-02727-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,7]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["2727"],"URL":"https:\/\/doi.org\/10.1007\/s00109-026-02727-0","relation":{},"ISSN":["0946-2716","1432-1440"],"issn-type":[{"value":"0946-2716","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,7]]},"assertion":[{"value":"10 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of the University of Innsbruck, Austria.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":5,"name":"Ethics","label":"Clinical trial number","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"117"}}